chr11-73234740-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_002564.4(P2RY2):c.581G>A(p.Arg194His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000397 in 1,610,194 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_002564.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
P2RY2 | NM_002564.4 | c.581G>A | p.Arg194His | missense_variant | 3/3 | ENST00000393597.7 | |
P2RY2 | NM_176071.3 | c.581G>A | p.Arg194His | missense_variant | 3/3 | ||
P2RY2 | NM_176072.3 | c.581G>A | p.Arg194His | missense_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
P2RY2 | ENST00000393597.7 | c.581G>A | p.Arg194His | missense_variant | 3/3 | 1 | NM_002564.4 | P1 | |
P2RY2 | ENST00000311131.6 | c.581G>A | p.Arg194His | missense_variant | 3/3 | 1 | P1 | ||
P2RY2 | ENST00000393596.2 | c.581G>A | p.Arg194His | missense_variant | 3/3 | 1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152216Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000485 AC: 12AN: 247576Hom.: 0 AF XY: 0.0000298 AC XY: 4AN XY: 134194
GnomAD4 exome AF: 0.0000357 AC: 52AN: 1457860Hom.: 0 Cov.: 56 AF XY: 0.0000345 AC XY: 25AN XY: 725430
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152334Hom.: 0 Cov.: 34 AF XY: 0.0000537 AC XY: 4AN XY: 74492
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 12, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at